LOGO-01.png
Burning Rock Announces the Launch of China’s First Prospective Interventional Validation Study on Multi-Cancer Early Detection - the PREVENT Study
June 30, 2022 10:57 ET | Burning Rock Biotech Limited
CHENGDU, China, June 30, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Burning Rock Announces Changes to Board Composition
June 24, 2022 03:26 ET | Burning Rock Biotech Limited
GUANGZHOU, China, June 24, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Burning Rock Announces US$10 Million Share Repurchase Program
June 21, 2022 02:03 ET | Burning Rock Biotech Limited
GUANGZHOU, China, June 21, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Burning Rock Announces Plan to Pursue An Alternative Listing
June 21, 2022 01:59 ET | Burning Rock Biotech Limited
GUANGZHOU, China, June 21, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Burning Rock Reports First Quarter 2022 Financial Results
May 31, 2022 02:32 ET | Burning Rock Biotech Limited
GUANGZHOU, China, May 31, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Burning Rock Schedules First Quarter of 2022 Earnings Release on May 31, 2022
May 16, 2022 04:00 ET | Burning Rock Biotech Limited
GUANGZHOU, China, May 16, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Burning Rock Reports Fourth Quarter and Full Year 2021 Financial Results
March 21, 2022 20:30 ET | Burning Rock Biotech Limited
GUANGZHOU, China, March 21, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Burning Rock Secures Second NGS Kit Approval from the NMPA
March 15, 2022 09:38 ET | Burning Rock Biotech Limited
GUANGZHOU, China, March 15, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that the National Medical Products Administration...
LOGO-01.png
Burning Rock to Release MRD Clinical Data on NSCLC and CRC at the Upcoming American Association for Cancer Research Annual Meeting
March 15, 2022 07:29 ET | Burning Rock Biotech Limited
GUANGZHOU, China, March 15, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that it will present MRD (molecular residual disease)...
LOGO-01.png
Burning Rock Schedules Fourth Quarter and Full Year 2021 Earnings Release on March 22, 2022
February 21, 2022 23:30 ET | Burning Rock Biotech Limited
GUANGZHOU, China, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...